(Total Views: 237)
Posted On: 11/28/2017 7:57:08 PM
Post# of 72446
You'd have to compare it to the previous one for differences. It was filed a few days before releasing top line data for the phase 2a trial. I haven't compared them but I would guess it's not a bad thing for them to be shoring up the patents. I don't think it means anything as this one was filed over a year and a half ago.
Perhaps there was a tweak in the patent that changes it enough to extend the patent protection? We did lose a lot of years between the first patent and now. If the drug works well, every extra year of patent adds value at the negotiating table.
Go IPIX!
Perhaps there was a tweak in the patent that changes it enough to extend the patent protection? We did lose a lot of years between the first patent and now. If the drug works well, every extra year of patent adds value at the negotiating table.
Go IPIX!
(2)
(0)
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
